News

IMUC

Will Investors Resuscitate These Beaten-Down Biotech Stocks?

The Life Sciences Report | Equities.com |

The list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who


How the Lack of R&D at Big Pharma Is Boosting Small Biotechs

The Life Sciences Report | Equities.com |

The recent pullback in biotech shares has not changed the time-tested theory of investing in small-cap drug development companies. Good or bad data will continue to move shares. In this interview


Biotech Investors Need to Focus on Catalysts

The Life Sciences Report | Equities.com |

When progress is made in drug development, value is created. Investors recognize that progress by purchasing shares in companies when milestones—which act as catalysts—are met. The


Stocks Under $10: Hold Rated Biomed/Genetics in the Medical Sector

Richard Suttmeier | Equities.com |

At www.ValuEngine.com we show that the Medical sector 10.6% overvalued with the Medical Biomed / Genetics 12.3% overvalued. All 16 stocks in today’s table have complete ValuEngine data and have


Equities Sector Coverage: Bulls Get the Green Light

Sector Recap | Equities.com |

Initial Jobless Claims fell 12,000 to 365,000 still above the 350,000 recessionary threshold. Non-manufacturing ISM came in at 53.7 in August, just above expectations. The Dow Jones Industrial


Equities Market Recap: Stocks Fall on Japan; Rise on Retail

Brittney Barrett | Equities.com |

U.S. stocks fell broadly on Thursday in the aftermath of a second earthquake striking in Japan. The 7.1 quake shook the Northeastern shore of Japan as well as international markets. The latter


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

Blockchain in Digital Identity - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Digital Identity